Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Kazani SD"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł :
Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.
Autorzy :
Calhoun WJ
Ameredes BT
King TS
Icitovic N
Bleecker ER
Castro M
Cherniack RM
Chinchilli VM
Craig T
Denlinger L
DiMango EA
Engle LL
Fahy JV
Grant JA
Israel E
Jarjour N
Kazani SD
Kraft M
Kunselman SJ
Lazarus SC
Pokaż więcej
Źródło :
JAMA: Journal of the American Medical Association; 9/12/2012, Vol. 308 Issue 10, p987-997, 11p
Czasopismo naukowe
Tytuł :
Prostaglandin D 2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP 2 receptor.
Autorzy :
Carstensen S; Department of Biomarker Analysis and Development, Clinical Airway Research, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.
Gress C; Department of Biomarker Analysis and Development, Clinical Airway Research, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.
Erpenbeck VJ; Novartis Pharma AG, Basel, Switzerland.
Kazani SD; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Hohlfeld JM; Department of Biomarker Analysis and Development, Clinical Airway Research, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany.; German Center for Lung Research (BREATH), Hannover, Germany.; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Sandham DA; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Müller M; Department of Biomarker Analysis and Development, Clinical Airway Research, Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany. .
Pokaż więcej
Źródło :
Respiratory research [Respir Res] 2021 Oct 07; Vol. 22 (1), pp. 262. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
Autorzy :
McEneny-King AC; Clinical Development and Translational Sciences, Clinical Pharmacology, Alexion Pharmaceuticals, Boston, MA, USA.
Monteleone JPR; Clinical Development and Translational Sciences, Pharmacometrics, Alexion Pharmaceuticals, Boston, MA, USA.
Kazani SD; Clinical Development and Translational Sciences, Alexion Pharmaceuticals, Boston, MA, USA.
Ortiz SR; Clinical Development and Translational Sciences, Clinical Pharmacology, Alexion Pharmaceuticals, Boston, MA, USA. .
Pokaż więcej
Źródło :
Infectious diseases and therapy [Infect Dis Ther] 2021 Jun; Vol. 10 (2), pp. 1045-1054. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial.
Autorzy :
Castro M; Washington University School of Medicine, St Louis, Missouri.
King TS; Penn State University, Hershey, Pennsylvania.
Kunselman SJ; Penn State University, Hershey, Pennsylvania.
Cabana MD; University of California, San Francisco.
Denlinger L; University of Wisconsin, Madison.
Holguin F; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Kazani SD; Brigham and Women's Hospital, Boston, Massachusetts.
Moore WC; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Moy J; Stroger Hospital of Cook County, Chicago, Illinois.
Sorkness CA; University of Wisconsin, Madison.
Avila P; Northwestern University, Chicago, Illinois.
Bacharier LB; Washington University School of Medicine, St Louis, Missouri.
Bleecker E; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Boushey HA; University of California, San Francisco.
Chmiel J; Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Fitzpatrick AM; Emory University, Atlanta, Georgia.
Gentile D; Allegheny General Hospital, Pittsburgh, Pennsylvania.
Hundal M; Duke University School of Medicine, Durham, North Carolina.
Israel E; Brigham and Women's Hospital, Boston, Massachusetts.
Kraft M; Duke University School of Medicine, Durham, North Carolina.
Krishnan JA; University of Illinois, Chicago.
LaForce C; North Carolina Clinical Research, Raleigh.
Lazarus SC; University of California, San Francisco.
Lemanske R; University of Wisconsin, Madison.
Lugogo N; Duke University School of Medicine, Durham, North Carolina.
Martin RJ; National Jewish Health, Denver, Colorado.
Mauger DT; Penn State University, Hershey, Pennsylvania.
Naureckas E; University of Chicago, Chicago, Illinois.
Peters SP; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Phipatanakul W; Boston Children's Hospital, Boston, Massachusetts.
Que LG; Duke University School of Medicine, Durham, North Carolina.
Sheshadri A; Washington University School of Medicine, St Louis, Missouri.
Smith L; Northwestern University, Chicago, Illinois.
Solway J; University of Chicago, Chicago, Illinois.
Sullivan-Vedder L; Aurora Sinai Medical Center, Milwaukee, Wisconsin.
Sumino K; Washington University School of Medicine, St Louis, Missouri.
Wechsler ME; National Jewish Health, Denver, Colorado.
Wenzel S; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
White SR; University of Chicago, Chicago, Illinois.
Sutherland ER; National Jewish Health, Denver, Colorado20Dr Sutherland is now with sanofi.
Pokaż więcej
Corporate Authors :
National Heart, Lung, and Blood Institute’s AsthmaNet
Źródło :
JAMA [JAMA] 2014 May; Vol. 311 (20), pp. 2083-91.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Adrenal Cortex Hormones/*administration & dosage
Asthma/*drug therapy
Cholecalciferol/*therapeutic use
Glucocorticoids/*administration & dosage
Pregnenediones/*administration & dosage
Vitamin D Deficiency/*drug therapy
Vitamins/*therapeutic use
Administration, Inhalation ; Administration, Oral ; Adult ; Anti-Asthmatic Agents/administration & dosage ; Asthma/complications ; Asthma/physiopathology ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Lung/drug effects ; Lung/physiopathology ; Male ; Middle Aged ; Treatment Failure ; Vitamin D Deficiency/complications
Czasopismo naukowe
Tytuł :
Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.
Autorzy :
Calhoun WJ; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA. />Ameredes BT
King TS
Icitovic N
Bleecker ER
Castro M
Cherniack RM
Chinchilli VM
Craig T
Denlinger L
DiMango EA
Engle LL
Fahy JV
Grant JA
Israel E
Jarjour N
Kazani SD
Kraft M
Kunselman SJ
Lazarus SC
Lemanske RF
Lugogo N
Martin RJ
Meyers DA
Moore WC
Pascual R
Peters SP
Ramsdell J
Sorkness CA
Sutherland ER
Szefler SJ
Wasserman SI
Walter MJ
Wechsler ME
Boushey HA
Pokaż więcej
Corporate Authors :
Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute
Źródło :
JAMA [JAMA] 2012 Sep 12; Vol. 308 (10), pp. 987-97.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Adrenal Cortex Hormones/*administration & dosage
Asthma/*drug therapy
Asthma/*physiopathology
Biomarkers/*analysis
Administration, Inhalation ; Adult ; Asthma/complications ; Breath Tests ; Double-Blind Method ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nitric Oxide/analysis ; Practice Guidelines as Topic ; Respiratory Function Tests ; Treatment Failure
Czasopismo naukowe
Tytuł :
Tiotropium bromide step-up therapy for adults with uncontrolled asthma.
Autorzy :
Peters SP; Wake Forest University Health Sciences, Center for Genomics and Personalized Medicine Research, Medical Center Blvd., Winston-Salem, NC 27157, USA. />Kunselman SJ
Icitovic N
Moore WC
Pascual R
Ameredes BT
Boushey HA
Calhoun WJ
Castro M
Cherniack RM
Craig T
Denlinger L
Engle LL
DiMango EA
Fahy JV
Israel E
Jarjour N
Kazani SD
Kraft M
Lazarus SC
Lemanske RF Jr
Lugogo N
Martin RJ
Meyers DA
Ramsdell J
Sorkness CA
Sutherland ER
Szefler SJ
Wasserman SI
Walter MJ
Wechsler ME
Chinchilli VM
Bleecker ER
Pokaż więcej
Corporate Authors :
National Heart, Lung, and Blood Institute Asthma Clinical Research Network
Źródło :
The New England journal of medicine [N Engl J Med] 2010 Oct 28; Vol. 363 (18), pp. 1715-26. Date of Electronic Publication: 2010 Sep 19.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Asthma/*drug therapy
Bronchodilator Agents/*therapeutic use
Cholinergic Antagonists/*therapeutic use
Scopolamine Derivatives/*therapeutic use
Administration, Inhalation ; Adult ; Albuterol/analogs & derivatives ; Albuterol/therapeutic use ; Beclomethasone/administration & dosage ; Bronchodilator Agents/adverse effects ; Cholinergic Antagonists/adverse effects ; Cross-Over Studies ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Glucocorticoids/administration & dosage ; Humans ; Male ; Peak Expiratory Flow Rate ; Salmeterol Xinafoate ; Scopolamine Derivatives/adverse effects ; Tiotropium Bromide
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies